Yu Jonathan Yen-Wen sold $1.3M of IRON
Yu Jonathan Yen-Wen (Chief Operating Officer) sold 18,612 shares of Disc Medicine, Inc. (IRON) at an average of $69.19 ($68.76–$69.92, $1.29M total) across 2 trades on 2026-06-16 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed event is an open-market sale by the COO totaling ~$1.29M, executed under a pre-arranged 10b5-1 plan.
Market read
Traders may monitor insider activity, but this specific disclosure is unlikely to drive a major repricing given the 10b5-1 structure and lack of new operating/financial information.
What to watch
The article provides no buy/sell context beyond this sale (e.g., total insider net activity, option exercises, or subsequent purchases), limiting inference.
Background
The article is an SEC Form 4 insider transaction disclosure for Disc Medicine, Inc. (IRON).
Ticker impact
Disc Medicine COO Yu Jonathan Yen-Wen sold about 18,612 shares in open-market transactions totaling ~$1.29M, per Form 4 filed June 18.
Likely limited near-term price impact; any effect would be sentiment-driven and small.
The filing specifies an open-market sale and that the trades were under a pre-arranged Rule 10b5-1 plan, which typically reduces interpretive signal versus discretionary selling.
Market effects
No sector-level implications; this is company-specific insider transaction disclosure.
None indicated.
None indicated.
Counterpoint
Even with a 10b5-1 plan, repeated insider sales can still be read by some traders as a mild caution signal about near-term outlook.
Key entities
- equity issuerIRON
Disc Medicine, Inc.; subject of the Form 4 insider transaction disclosure.
- insiderYu Jonathan Yen-Wen
Chief Operating Officer who sold shares in open-market transactions under a 10b5-1 plan.